| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3190365 | Annales de Dermatologie et de Vénéréologie | 2006 | 4 Pages |
Abstract
Laboratory monitoring (NFS, liver enzymes) is thus justified, particularly after the first and second courses of DTIC. In case of fever and hypereosinophilia without liver dysfunction, DTIC may be continued together with symptomatic treatment. In the event of hepatic dysfunction, and of course severe hematological disorders, potentially fatal complications can occur and treatment must be stopped.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
A. Levy, P. Guitera, D. Kerob, L. Ollivaud, A. Archimbaud, L. Dubertret, N. Basset-Seguin,